Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads [NA]
Clinical trial update on a program for heart failure patients and family caregiver dyads; results posted after completion.
-
FDA approval · 2022-02-24FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Jardiance (empagliflozin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2022-02-24FDA Approved: ENALAPRIL MALEATE ORAL SOLUTION — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's enalapril maleate oral solution as an original ANDA, enabling a generic version of enalapril maleate.
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart Failure [NA]
Clinical trial update on compression wraps as adjuvant therapy for acute systolic heart failure; study terminated with posted results in 202…
-
FDA approval · 2022-02-24FDA Approved: CHLORTHALIDONE — Original Application (TAGI Pharma, Inc.)
FDA approved the original generic application for chlorthalidone by TAGI Pharma, Inc., allowing market authorization for this thiazide-like …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure [Phase 4]
Phase 4 trial update evaluating dapagliflozin in type 2 diabetes patients with decompensated heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients [NA]
A completed clinical trial investigating initiation of CPAP therapy for newly diagnosed obstructive sleep apnea in hospitalized heart failur…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Heart Failure and Sudden Cardiac Death Japan Registry
Completed registry study in Japan assessing heart failure, arrhythmias, and sudden cardiac death outcomes with sponsor Boston Scientific.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease [Phase 2]
Phase 2 dose-finding trial update for BAY94-8862 in chronic heart failure with mild to moderate chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure [Phase 4]
Phase 4 clinical trial update evaluating influenza vaccination in patients with acute coronary syndrome and chronic heart failure during the…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study [Phase 2]
Phase 2 pilot study evaluating the use of statins for primary prevention of heart failure in patients receiving anthracycline therapy.
-
FDA approval · 2022-02-08FDA Approved: DIGOXIN — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic digoxin product, enabling marketing in the United States.
-
FDA approval · 2022-01-27FDA Approved: FUROSEMIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved an original generic application for furosemide from Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly [NA]
The trial evaluated implantable cardioverter-defibrillator implantation in elderly patients with cardiomyopathy and coronary artery disease,…
-
FDA label_change · 2022-01-12FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) to update the labeling, submitted by Melinta Therapeutics, LLC.
-
CLINICAL_TRIALS withdrawal · 2021-12-30Clinical Trial Update: Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: [Phase 4]
A Phase 4 trial update concerning withdrawal of pharmacological treatment in patients who respond to cardiac resynchronization therapy (CRT)…
-
FDA approval · 2021-12-23FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisinopril submitted by Camber Pharmaceuticals, Inc., approving changes to the lisinopril pr…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Effect of Chronic Changes in Heart Rate on Congestive Heart Failure [NA]
A completed clinical trial from University of Maryland on how chronic changes in heart rate affect congestive heart failure; results posted …
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Contribution of Endothelin-1 to Exercise Intolerance in Heart Failure [EARLY_Phase 1]
Early-phase study investigating the contribution of Endothelin-1 to exercise intolerance in heart failure; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Empagliflozin Impact on Hemodynamics in Patients With Heart Failure [Phase 4]
Phase 4 trial investigating empagliflozin's impact on hemodynamics in patients with heart failure has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure [Phase 4]
Clinical trial comparing spironolactone and indapamide, alone or with amlodipine, for reducing heart failure risk in hypertension (Phase 4).
-
FDA approval · 2021-12-06FDA Approved: VALSARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for valsartan submitted by Aurobindo Pharma Limited, updating the existing approval for this generic…
-
FDA approval · 2021-12-06FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for VALSARTAN from Macleods Pharmaceuticals Limited. This approval supports continued distribution o…
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) [Phase 4]
Phase 4 LIFE study update for Entresto (LCZ696) in advanced heart failure; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System [NA]
Clinical trial update for the Continued Access Protocol evaluating the OPTIMIZER Smart System in heart failure patients; the study is termin…